- Watts, Eleanor L;
- Perez‐Cornago, Aurora;
- Appleby, Paul N;
- Albanes, Demetrius;
- Ardanaz, Eva;
- Black, Amanda;
- Bueno‐de‐Mesquita, H Bas;
- Chan, June M;
- Chen, Chu;
- Chubb, SA Paul;
- Cook, Michael B;
- Deschasaux, Mélanie;
- Donovan, Jenny L;
- English, Dallas R;
- Flicker, Leon;
- Freedman, Neal D;
- Galan, Pilar;
- Giles, Graham G;
- Giovannucci, Edward L;
- Gunter, Marc J;
- Habel, Laurel A;
- Häggström, Christel;
- Haiman, Christopher;
- Hamdy, Freddie C;
- Hercberg, Serge;
- Holly, Jeff M;
- Huang, Jiaqi;
- Huang, Wen‐Yi;
- Johansson, Mattias;
- Kaaks, Rudolf;
- Kubo, Tatsuhiko;
- Lane, J Athene;
- Layne, Tracy M;
- Le Marchand, Loic;
- Martin, Richard M;
- Metter, E Jeffrey;
- Mikami, Kazuya;
- Milne, Roger L;
- Morris, Howard A;
- Mucci, Lorelei A;
- Neal, David E;
- Neuhouser, Marian L;
- Oliver, Steven E;
- Overvad, Kim;
- Ozasa, Kotaro;
- Pala, Valeria;
- Pernar, Claire H;
- Pollak, Michael;
- Rowlands, Mari‐Anne;
- Schaefer, Catherine A;
- Schenk, Jeannette M;
- Stattin, Pär;
- Tamakoshi, Akiko;
- Thysell, Elin;
- Touvier, Mathilde;
- Trichopoulou, Antonia;
- Tsilidis, Konstantinos K;
- Van Den Eeden, Stephen K;
- Weinstein, Stephanie J;
- Wilkens, Lynne;
- Yeap, Bu B;
- Key, Timothy J;
- Allen, Naomi E;
- Travis, Ruth C
Insulin-like growth factors (IGFs) and insulin-like growth factor binding proteins (IGFBPs) have been implicated in the aetiology of several cancers. To better understand whether anthropometric, behavioural and sociodemographic factors may play a role in cancer risk via IGF signalling, we examined the cross-sectional associations of these exposures with circulating concentrations of IGFs (IGF-I and IGF-II) and IGFBPs (IGFBP-1, IGFBP-2 and IGFBP-3). The Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset includes individual participant data from 16,024 male controls (i.e. without prostate cancer) aged 22-89 years from 22 prospective studies. Geometric means of protein concentrations were estimated using analysis of variance, adjusted for relevant covariates. Older age was associated with higher concentrations of IGFBP-1 and IGFBP-2 and lower concentrations of IGF-I, IGF-II and IGFBP-3. Higher body mass index was associated with lower concentrations of IGFBP-1 and IGFBP-2. Taller height was associated with higher concentrations of IGF-I and IGFBP-3 and lower concentrations of IGFBP-1. Smokers had higher concentrations of IGFBP-1 and IGFBP-2 and lower concentrations of IGFBP-3 than nonsmokers. Higher alcohol consumption was associated with higher concentrations of IGF-II and lower concentrations of IGF-I and IGFBP-2. African Americans had lower concentrations of IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 and Hispanics had lower IGF-I, IGF-II and IGFBP-3 than non-Hispanic whites. These findings indicate that a range of anthropometric, behavioural and sociodemographic factors are associated with circulating concentrations of IGFs and IGFBPs in men, which will lead to a greater understanding of the mechanisms through which these factors influence cancer risk.